Browse > Article

Long Term Feeding with Soy Isoflavone and L-Carnitine Synergistically Suppresses Body Weight Gain and Adiposity in High-Fat Diet Induced Obese Mice  

Park Hyun-Woo (Food Research Institute, AmorePacific Corporation R&D Center)
Yang Mi-Suk (Food Research Institute, AmorePacific Corporation R&D Center)
Lee Ji-Hae (Food Research Institute, AmorePacific Corporation R&D Center)
Shin Eui-Seok (Food Research Institute, AmorePacific Corporation R&D Center)
Kim Yoo (Food Research Institute, AmorePacific Corporation R&D Center)
Chun Ji-Young (Food Research Institute, AmorePacific Corporation R&D Center)
Lee Tae-Ryong (Food Research Institute, AmorePacific Corporation R&D Center)
Lee Sang-Jun (Food Research Institute, AmorePacific Corporation R&D Center)
Publication Information
Nutritional Sciences / v.9, no.3, 2006 , pp. 179-189 More about this Journal
Abstract
Objective: We investigated the efficacy of a 12-week supplementation of soy isoflavone with L-carnitine on the development of obesity in high fat-induced obese C57BL/6J mice, which are known as a good model of diet-induced obesity. Methods: We measured body weights, adipose tissue mass, serum/liver lipid profiles and fat cell size/number in C57BL/6J mice fed diets containing either low fat (4%) or high fat (35%), or high fat supplemented with soy isoflavone powder containing 10% isoflavone and L-camitine for 12 weeks. Results: Body weight gain, abdominal adipose tissue and liver weight were lower by 31% 78% and 31.4% respectively, in mice on high fat diet containing soy isoflavone+L-carnitine (SC mixture) compared with high fat diet group. Also, SC mixture improved serum lipid profiles such as total cholesterol (TC), triglycerides (TG), and liver lipid profiles such as total lipids and TG. As subsequent results, this SC mixture prevented high-fat diet from accumulating TG in the liver. The size of fat cell was also significantly decreased in SC mixture fed mice. At the end point of this experiment, our results showed that feeding with soy isoflavone for 12 weeks finally increased camitine palmitoyltransferase 1 (CPT 1) activity through elevating the level of CPT1 expression. Conclusions: This study suggests that long-tenn supplementation with dietary soy isoflavone and L-carnitine is more synergistically beneficial for the suppression of high-fat diet induced obesity by inhibiting liver TG accumulation and the gain in abdominal adipose tissue weight than that with soy isoflavone. The antiobesity effects of SC mixture might be attributed, at least in part, to the induction of fatty acid catabolism by soy isoflavone, genistein.
Keywords
Soy isoflavone; Obesity; High-fat diet; Carnitine palmitoyltransferase 1; Lipid profile;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Dixon RA, Ferreira D. Genistein Phytochemistry 60(3):205-211, 2002   DOI   ScienceOn
2 Kojima T, Uesugi T, Toda T, Miura Y, Yagasaki K. Hypolipidemic action of the soybean isoflavones genistein and genistin in glomerulonephritic rats. Lipids 37(3):261-265, 2002   DOI   ScienceOn
3 Schleicher RL, Lamartiniere CA, Zheng M, Zhang M. The inhibitory effect of genistein on the growth arid metastasis of a transplantable rat accessory sex gland carcinoma. Cancer Lett 136(2):195-201, 1999   DOI   ScienceOn
4 West DB, Boozer CN, Moody DL, Atkinson RL. Dietary obesity in nine inbred mouse strains. Am J Physiol 262 (6 Pt 2):R1025-1032, 1992
5 Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37(8):911-917; 1959   DOI   ScienceOn
6 Jensen B, Farach-Carson MC, Kenaley E, Akanbi KA. High extracellular calcium attenuates adipogenesis in 3T3-L1 preadipocytes. Exp Cell Res 301(2):280-292, 2004   DOI   ScienceOn
7 Brix AE, Elgavish A, Nagy TR, Gower BA, Rhead WJ, Wood PA. Evaluation of liver fatty acid oxidation in the leptin-deficient obese mouse. Mol Genet Metab 75(3):219-226, 2002   DOI   ScienceOn
8 Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene.Science 269(5223):543-546, 1995   DOI
9 fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36(1):54-59, 1987   DOI   ScienceOn
10 Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 29(2):95-120, 1997   DOI
11 Kozak LP, Jensen JT. Genetic and developmental control of multiple forms of L-glycerol 3-phosphate dehydrogenase. J Biol Chem 249(24):7775-7781, 1974
12 Lichtenstein AH, Kennedy E, Barrier P, Danford D, Ernst ND, Grundy SM, Leveille GA, Van Horn L, Williams CL, Booth SL. Dietary fat consumption and health. Nutr Rev 56(5 Pt 2):S3-28, 1998
13 Lonnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1(9):950-953, 1995   DOI
14 Harmon AW, Harp JB. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am J Physiol Cell Physiol 280(4):C807-813, 2001   DOI
15 Goodman-Gruen D, Kritz-Silverstein D. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131(4):1202-1206, 2001
16 Wise LS, Green H. Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells. J Biol Chem 254(2):273-275, 1979
17 McGarry JD, Robles-Valdes C, Foster DW. Role of carnitine in hepatic ketogenesis. Proc Natl Acad Sci US4 72(11):4385-4388, 1975
18 Velasquez MT, Bhathena SJ. Dietary phytoestrogens: a possible role in renal disease protection. Am J Kidney Dis 37(5): 1056-1068, 2001   DOI   ScienceOn
19 Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76(6):1191-1201, 2002   DOI
20 Kim S, Shin HJ, Kim SY, Kim JH, Lee YS, Kim DH, Lee MO. Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha. Mol Cell Endoerinol 220(1-2):51-58, 2004   DOI   ScienceOn
21 Linn TC. Purification and crystallization of rat liver fatty acid synthetase. Arch Biochem Biophys 209(2):613-619, 1981   DOI   ScienceOn
22 Murase T, Mizuno T, Omachi T, Onizawa K, Komine Y, Kondo H, Hase T, Tokimitsu I. Dietary diacylglycerol suppresses high fat and high sucrose diet-induced body fat accumulation in C57BL/6J mice. J Lipid Res 42(3):372-378, 2001
23 Michael MR, Wolz E, Davidovich A, Pfannkuch F, Edwards JA, Bausch J. Acute, subchronic and chronic safety studies with genistein in rats. Food Chem Toxicol 44(1):56-80, 2006   DOI   ScienceOn
24 Lissin LW, Cooke JP. Phytoestrogens and cardiovascular health. J Am Coll Cardiol 35(6):1403-1410, 2000   DOI   ScienceOn
25 Libinaki R, Heffernan M, Jiang WJ, Ogru E, Ignjatovic V, Gianello R, Trickey L, Taylor M, Ng F. Effects of genetic and diet-induced obesity on lipid metabolism. IUBMB Life 48(1):109-113, 1999   DOI
26 WHO. Report of a WHO Consultation on Obesity. Obesity: preventing and managing the global epidemic. World Health Organization, 1998
27 Houseknecht KL, Baile CA, Matteri RL, Spurlock ME. The biology of leptin: a review. J Anim Sci 76(5):1405-1420, 1998
28 Messina MJ. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr 70(3 Suppl):439S-450S, 1999
29 Eaton S. Control of mitochondrial beta-oxidation flux. Prog Lipid Res 41(3): 197-239, 2002   DOI   ScienceOn
30 Nogowski L, Mackowiak P, Kandulska K, Szkudelski T, Nowak KW. Genistein-induced changes in lipid metabolism of ovariectomized rats. Ann Nutr Metab 42(6):360-366, 1998   DOI   ScienceOn
31 McGarry JD, Mills SE, Long CS, Foster DW. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214(1):21-28, 1983   DOI
32 Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20(5): 649-688, 1999   DOI   ScienceOn
33 Anderson JW, Smith BM, Washnock CS. Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr 70(3 Suppl):464S-474S, 1999
34 Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L, Clarkson TB. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism 46(6):698-705, 1997   DOI   ScienceOn
35 Shin ES, Cho SY, Lee EH, Lee SJ, Chang IS, Lee TR. Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine. Eur J Nutr 45(3):159-164, 2006   DOI
36 Szkudelska K, Nogowski L, Szkudelski T. Genistein affects lipogenesis and lipolysis in isolated rat adipocytes. J Steroid Biochem Mol Biol 75(4-5):265-271, 2000   DOI
37 Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1(11):1155-1161, 1995   DOI
38 Tham DM, Gardner CD, Haskell WL. Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 83(7):2223-2235, 1998   DOI
39 Zierz S, Engel AG. Different sites of inhibition of carnitine palmitoyltransferase by malonyl-CoA, and by acetyl-CoA and CoA, in human skeletal muscle. Biochem J 245(1):205-209, 1987   DOI
40 Kim S, Sohn I, Lee YS, Lee YS. Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. J Nutr 135(1):33-41, 2005   DOI
41 Mezeio O, Banz WJ, Steger RW, Peluso MR, Winters TA, Shay N. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 133(5):1238-1243, 2003
42 Han LK, Xu BJ, Kimura Y, Zheng Y, Okuda H. Platycodi radix affects lipid metabolism in mice with high fat diet-induced obesity. J Nutr 130(11):2760-2764, 2000
43 Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103(11):1489-1498, 1999   DOI   ScienceOn